1 – 10 of 24
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Statins and postmenopausal breast cancer risk; results from the KARMA cohort
- Contribution to journal › Article
-
Mark
HER2-targeted PET-imaging with [68Ga]Ga-ABY-025 to predict targeted-therapy response in HER2-expressing metastatic breast cancer : study protocol of a multicenter, prospective, open-label trial
- Contribution to journal › Article
- 2023
-
Mark
FGF/FGFR1 system in paired breast tumor-adjacent and tumor tissues, associations with mammographic breast density and tumor characteristics
- Contribution to journal › Article
-
Mark
Obesity and breast cancer prognosis : pre-diagnostic anthropometric measures in relation to patient, tumor, and treatment characteristics
- Contribution to journal › Article
- 2022
-
Mark
Postmenopausal overweight and breast cancer risk; results from the KARMA cohort
- Contribution to journal › Article
-
Mark
Physical Activity and Long-Term Risk of Breast Cancer, Associations with Time in Life and Body Composition in the Prospective Malmö Diet and Cancer Study
- Contribution to journal › Article
- 2020
-
Mark
Prognostic implications of the expression levels of different immunoglobulin heavy chain-encoding RNAs in early breast cancer
- Contribution to journal › Article
- 2019
-
Mark
Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer
- Contribution to journal › Article
- 2018
-
Mark
Novel 18-gene signature for predicting relapse in ER-positive, HER2-negative breast cancer
- Contribution to journal › Article
- 2017
-
Mark
Androgen Receptor in Stage I-II Primary Breast Cancer -Prognostic Value and Distribution in Subgroups
- Contribution to journal › Article
